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pression of PD-1 and CTLA-4 on the HBV-speciﬁc T cells, which
may associate with the low ability of HBV-speciﬁc T-cell re-
sponses, high serum HBV DNA levels and high percentage of liver
cirrhosis in HBeAg(+) patients.
OL-051 Regulatory polymorphisms in the IL-10 gene
promoter and HBV-related acute liver failure in
the Chinese population
Zehui Yan*, Guohong Deng, Wenting Tan, Xiaohong Wang,
Qing Mao, Yuming Wang. Department of Infectious Diseases,
Southwest Hospital, The Third Military Medical University,
Chongqing, PR China
Background: Recent reports indicated that high levels of IL-
10 contribute to the monocytes paralysation and poor clinical
outcome in acute liver failure (ALF).
The aim of this study was to determine the possible associa-
tion of the polymorphisms in the IL-10 gene promoter with the
susceptibility to HBV-related ALF.
Methods: The IL-10 gene promoter polymorphisms were geno-
typed in 414 unrelated healthy blood donors, 367 asymptomatic
HBV carriers and 345 HBV-related ALF patients using the poly-
merase chain reaction-restriction fragment length polymorphism
assay or ampliﬁcation refractory mutation system-polymerase
chain reaction. Functional analyses were conducted to verify the
biological signiﬁcances of the associated genetic variations.
Results: The allele frequencies of IL-10 -592C and -819C were sig-
niﬁcantly higher in HBV-related ALF patients than in blood donors
and asymptomatic HBV carriers. Logistic regression analysis and
stratiﬁcation analysis with adjustment for age and sex indicated
that the polymorphisms of A-592C and T-819C were associated
with susceptibility to HBV-related ALF (P = 6.9×10−7), and the
-1082A-819C-592C haplotype in the IL-10 gene promoter were
associated with an increased susceptibility to ALF in HBV carriers
(dominant model, P = 0.0002, OR = 1.60, 95%CI 1.25-2.07). Func-
tional analyses showed that the A-592C polymorphism is a nuclear
proteins binding site, and the disease susceptible -592C allele
had a higher transcription activity compared with -592A allele.
Conclusions: Our study emphasizes the importance of IL-10 in
the pathophysiology of HBV-related ALF on the population level.
OL-052 A mathematical model with time-delay immune
response for adefovir treatment
Shaopeng Chen, Yongmei Su, Lequan Min*. Applied Science
School, University of Science and Technology, Beijing
Objectives: The immune response is often initiated with time-
delay and HBV DNA always rebound with shaking after stopping
treatment. Based on K Borroto-Esoda et.al’s adefovir clinical
data and the HBV infection dynamic model proposed by Nowak
et al., we set up a mathematical model with time delay immune
response to simulate the viral dynamics of the clinical data.
Methods: A model of HBV is described by four variables: x, y,
v, z represent uninfected cells, infected cells, free virus, and
immune system effector cells, respectively. The model includes
11 parameters: λ, d, β, a, p, k, k2, u, c, b, τ. The meanings of λ,
d, β, a, k and u are the same as those given in Nowak’s model,
k2 represents the curative effect, and τ represents time-delay.
During treatment, we choose {λ, d, β, a, p, k, k2, u, c, b, τ}
= {4.621×105, 6.9×10-3, 0.0708, 6.9×10-3, 1.5×10-9, 2.9, 2.832,
0.68, 0.35, 0.02251, 10.6}. During off-treatment, we choose k2=0
with other parameters unchanged.
Results: The simulation data of our model are qualitatively
agreement with the clinical ones, especially the HBV DNA re-
bound shaking data during the off-treatment.
Conclusion: The results show that our time-delay immune model
may possibly capture the dynamics of HBV infection and anti-HBV
infection treatment.
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Objective: To understand the polymorphism of HLA-DRB1 of the
Uyghurs in Khotan Area, Xinjiang, China and the association with
chronic hepatisis B.
Methods: Reverse-polymerase chain reaction sequence speciﬁc
oligonucleotide probes (PCR SSOP) combined with Luminex Flow
Cytometry were used to genotype HLA-DRB1 alleles in 56 unre-
lated healthy Uyghurs controls and 41 chronic hepatisis B Uyghurs
patients of Khotan Area, Xinjiang, China.
Results: 13 DRB1 alleles covered all serology speciﬁcities could
be detected, and their frequencies were calculated in 2 groups.
Conclusion: This study provided the normal allele frequencies
of HLA-DRB1 and linkage disequilibrium with chronic hepatisis
B in Uyghurs in Khotan Area, Xinjiang of China, which may be
of signiﬁcance in the studies on population genetics and disease
association.
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Objectives: To investigate the identiﬁcation methods of the new
serotype 6C; Surveillance the antimicrobial susceptibility and
molecular epidemiology of the new serotype 6C Streptococcus
Pneumonmiae from China.
Methods: The new serotype 6C Streptococcus Pneumonmiae
were determined by multibean assay in USA, Serological method
using the antiserum of 6C in our laboratory and molecular biology
method by multiplex PCR ampliﬁcation of capsular gene targets.
Antimicrobial susceptibility to erythromycin and beta-lactam an-
tibiotic were detected by E-Test. PCR was used to detect genes
ermB and mefA. The typing methods of molecular biology were
used to show the homology of all serotype 6C strains.
Results: 10 serotype 6C isolates were determined from 100
serotype 6A by the three methods, 9 were isolated in Beijing
and 1 in Guangzhou, 6 strains were isolated in Beijing in 1997.
All strains of serotype 6C were resistant to erythromycin but
susceptible to beta-lactam antibiotic. 8 isolates were detected
only ermB and 2 only mefA. All isolates of serotype 6C were
distributed 3 Pbps types, 4 PFGE types and 4 MLST types respec-
tively. Pbps types I, PFGE types I and MLST types I include 6, 7
and 7 strains respectively.
Conclusions:There were three methods can be used to deter-
mine the new serotype 6C Streptococcus Pneumonmiae. The new
serotype 6C could be mainly identiﬁed ten years ago in China
and all strains were susceptible to beta-lactam antibiotic but
resistant to erythromycin.The gene typing present a diversity,
but more isolates were in one type.
